Ginkgo biloba for cognitive impairment and dementia

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 7, 2020, Pages

  Wieland, L Susan ^a   Feinberg, Termeh M ^b   Ludeman, Emilie ^c   Prasad, Nikhil K ^a   Amri, Hakima ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGO BILOBA EXTRACT;

ARTICLE; COGNITIVE DEFECT; COGNITIVE FUNCTION TEST; DEMENTIA; DRUG EFFICACY; DRUG SAFETY; EXECUTIVE FUNCTION; HUMAN; MENTAL PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; QUALITY OF LIFE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 85087305927     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD013661     Document Type: Article

References (61)

1. Alzheimer's Disease International. Dementia Statistics. www.alz.co.uk/research/statistics (accessed 5 November 2019).
2. Amri H, Ogwuegbu SO, Boujrad N, Drieu K, Papadopoulos V. In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides. Endocrinology 1996;137(12):5707-18. [PMID: 8940403]
3. Amri H, Drieu K, Papadopoulos V. Use of ginkgolide B and a ginkgolide-activated response element to control gene transcription: example of the adrenocortical peripheral-type benzodiazepine receptor. Cellular and Molecular Biology (Noisy-le-Grand, France) 2002;48(6):633-9. [PMID: 12396073]
4. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Arlington (VA): American Psychiatric Association, 2013.
5. Bader BM, Jugelt K, Schultz L, Schroeder OH. Ginkgo biloba L. (Ginkgoaceae) leaf extract medications from different providers exhibit differential functional effects on mouse frontal cortex neuronal networks. Frontiers in Pharmacology 2018;9:848. [PMID: 30123130]
6. Baron-Ruppert G, Luepke NP. Evidence for toxic effects of alkylphenols from Ginkgo biloba in the hen's egg test (HET). Phytomedicine 2001;8(2):133-8.
7. Benzie IF, Wachtel-Galor S (editors). Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis, 2011.
8. Camfield D, McIntyre E, Sarris J (Editors). Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders. 1st edition. New York, NY: Springer Berlin Heidelberg, 2016.
9. Dawson W. Winning the fight to end Alzheimer disease. JAMA Neurology 2017;74(8):896-7. [PMID: 28672290]
10. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
11. Drieu K, Vranckx R, Benassayad C, Haourigi M, Hassid J, Yoa RG, et al. Effect of the extract of Ginkgo biloba (EGb 761) on the circulating and cellular profiles of polyunsaturated fatty acids: correlation with the anti-oxidant properties of the extract. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2000;63(5):293-300. [PMID: 11090256]
12. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34. [PMID: 9310563]
13. Elahi FM, Miller BL. A clinicopathological approach to the diagnosis of dementia. Nature Reviews. Neurology 2017;13(8):457-76. [PMID: 28708131]
14. Feng Z, Sun Q, Chen W, Bai Y, Hu D, Xie X. The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review. Molecular Medicine (Cambridge, Mass.) 2019;25(1):57. [PMID: 31864312]
15. Gargouri B, Carstensen J, Bhatia HS, Huell M, Dietz GPH, Fiebich BL. Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2018;44:45-55. [PMID: 29895492]
16. Gauthier S, Schlaefke S. Efficacy and tolerability of Ginkgo biloba extract EGb 761(R) in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials. Clinical Interventions in Aging 2014;9:2065-77. [PMID: 25506211]
17. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Archives of Neurology 2004;61(1):59-66. [PMID: 14732621]
18. Harada CN, Natelson Love MC, Triebel KL. Normal cognitive aging. Clinics in Geriatric Medicine 2013;29(4):737-52. [PMID: 24094294]
19. Higgins JPT, Altman DG, Sterne JAC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Available from www.training.cochrane.org/handbook.
20. Higgins JPT, Eldridge S, Li T (editors). Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
21. Isah T. Rethinking Ginkgo biloba L.: Medicinal uses and conservation. Pharmacognosy Reviews 2015;9(18):140-8. [PMID: 26392712]
22. Jiang M, Li J, Peng Q, Liu Y, Liu W, Luo C, et al. Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. Journal of Neuroinflammation 2014;11:167. [PMID: 25256700]
23. Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. MMWR Supplements 2014;63(4):3-27. [PMID: 25356673]
24. Kandiah N, Ong PA, Yuda T, Ng LL, Mamun K, Merchant RA, et al. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761((R)). CNS Neuroscience & Therapeutics 2019;25(2):288-98. [PMID: 30648358]
25. Kuo LC, Song YQ, Yao CA, Cheng IH, Chien CT, Lee GC, et al. Ginkgolide A prevents the amyloid-beta-Induced depolarization of cortical neurons. Journal of Agricultural and Food Chemistry 2019;67(1):81-9. [PMID: 30541279]
26. Lejri I, Grimm A, Eckert A. Ginkgo biloba extract increases neurite outgrowth and activates the Akt/mTOR pathway. PloS One 2019;14(12):e0225761. [PMID: 31790465]
27. Lejri I, Agapouda A, Grimm A, Eckert A. Mitochondria- and oxidative stress-targeting substances in cognitive decline-related disorders: from molecular mechanisms to clinical evidence. Oxidative Medicine and Cellular Longevity 2019;2019:9695412. [PMID: 31214285]
28. Li H, Sun X, Yu F, Xu L, Miu J, Xiao P. In silico investigation of the pharmacological mechanisms of beneficial effects of Ginkgo biloba L. on Alzheimer's disease. Nutrients 2018;10(5):589. [PMID: 29747475]
29. Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet (London, England) 2017;390(10113):2673-734. [PMID: 28735855]
30. Luo Y, Smith JV, Paramasivam V, Burdick A, Curry KJ, Buford JP, et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proceedings of the National Academy of Sciences of the United States of America 2002;99(19):12197-202. [PMID: 12213959]
31. McKenna DJ, Jones K, Hughes K. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Alternative Therapies in Health and Medicine 2001;7(5):70-86, 88-90. [PMID: 11565403]
32. Montes P, Ruiz-Sanchez E, Rojas C, Rojas P. Ginkgo biloba Extract 761: a review of basic studies and potential clinical use in psychiatric disorders. CNS & Neurological Disorders Drug Targets 2015;14(1):132-49. [PMID: 25642989]
33. Moreira HS, Costa AS, Machado A, Castro SL, Lima CF, Vicente SG. Distinguishing mild cognitive impairment from healthy aging and Alzheimer's Disease: the contribution of the INECO Frontal Screening (IFS). PloS One 2019;14(9):e0221873. [PMID: 31504056]
34. Nabavi SM, Habtemariam S, Daglia M, Braidy N, Loizzo MR, Tundis R, et al. Neuroprotective effects of ginkgolide B against ischemic stroke: a review of current literature. Current Topics in Medicinal Chemistry 2015;15(21):2222-32. [PMID: 26059355]
35. Newman, A, Cauley, JA, editor(s). The Epidemiology of Aging. Springer Science & Business Media, 2012.
36. National Institutes of Health. The Dementias: Hope Through Research. www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research/Dementia-Hope-Through-Research (accessed 20 January 2020).
37. Qin Y, Zhang Y, Tomic I, Hao W, Menger MD, Liu C, et al. Ginkgo biloba Extract EGb 761 and its specific components elicit protective protein clearance through the autophagy-lysosomal pathway in tau-transgenic mice and cultured neurons. Journal of Alzheimer's Disease 2018;65(1):243-63. [PMID: 30010136]
38. Rapp M, Burkart M, Kohlmann T, Bohlken J. Similar treatment outcomes with Ginkgo biloba extract EGb 761 and donepezil in Alzheimer's dementia in very old age: A retrospective observational study. International Journal of Clinical Pharmacology and Therapeutics 2018;56(3):130-3. [PMID: 29319499]
39. Savaskan E, Mueller H, Hoerr R, von Gunten A, Gauthier S. Treatment effects of Ginkgo biloba extract EGb 761(R) on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials. International Psychogeriatrics / IPA 2018;30(3):285-93. [PMID: 28931444]
40. Schünemann HJ, Higgins JPT, Vist GE, Glasziou P, Akl EA, Skoetz N, Guyatt GH. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
41. Shi R, Wang Y, An X, Ma J, Wu T, Yu X, et al. Efficacy of co-administration of Liuwei Dihuang pills and Ginkgo Biloba tablets on albuminuria in type 2 diabetes: A 24-Month, multicenter, double-blind, placebo-controlled, randomized clinical trial. Frontiers in Endocrinology 2019;10:100. [PMID: 30873118]
42. Singh B, Kaur P, Gopichand, Singh RD, Ahuja PS. Biology and chemistry of Ginkgo biloba. Fitoterapia 2008;79(6):401-18.
43. Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics 2019;16(3):666-74. [PMID: 31376068]
44. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (Clinical Research Ed.) 2011;343:d4002. [PMID: 21784880]
45. Tan MS, Yu JT, Tan CC, Wang HF, Meng XF, Wang C, et al. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. Journal of Alzheimer's Disease 2015;43(2):589-603. [PMID: 25114079]
46. Tian J, Liu Y, Chen K. Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications. Current vascular pharmacology 2017;15(6):532-48. [PMID: 28707602]
47. Tulsulkar J, Glueck B, Hinds TD Jr, Shah ZA. Ginkgo biloba extract prevents female mice from ischemic brain damage and the mechanism is independent of the HO1/Wnt pathway. Translational Stroke Research 2016;7(2):120-31. [PMID: 26573919]
48. Tunali-Akbay T, Sener G, Salvarli H, Sehirli O, Yarat A. Protective effects of Ginkgo biloba extract against mercury(II)-induced cardiovascular oxidative damage in rats. Phytotherapy Research: PTR 2007;21(1):26-31. [PMID: 17072828]
49. Usuki T, Yoshimoto Y, Sato M, Takenaka T, Takezawa R, Yoshida Y, et al. Bilobalide and PC12 cells: A structure activity relationship study. Bioorganic & Medicinal Chemistry 2020;28(2):115251. [PMID: 31848115]
50. World Health Organization (WHO). Ageing and Health. www.who.int/news-room/fact-sheets/detail/ageing-and-health (accessed 5 February 2018).
51. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 2004;256(3):240-6. [PMID: 15324367]
52. Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, Klein WL, et al. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. Journal of Neuroscience 2006;26(50):13102-13. [PMID: 17167099]
53. Wu TC, Chen JS, Wang CH, Huang PH, Lin FY, Lin LY, et al. Activation of heme oxygenase-1 by Ginkgo biloba extract differentially modulates endothelial and smooth muscle-like progenitor cells for vascular repair. Scientific reports 2019;9(1):17316. [PMID: 31754254]
54. Yang Shouzhong. The Divine Farmer's Materia Medica: a translation of the Shen Nong Ben Cao Jing. Boulder, CO: Blue Poppy Press, 1998.
55. Yang G, Wang Y, Sun J, Zhang K, Liu J. Ginkgo biloba for mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials. Current Topics in Medicinal Chemistry 2016;16(5):520-8. [PMID: 26268332]
56. Yuan Q, Wang CW, Shi J, Lin ZX. Effects of Ginkgo biloba on dementia: An overview of systematic reviews. Journal of Ethnopharmacology 2017;195:1-9. [PMID: 27940086]
57. Zeng K, Li M, Hu J, Mahaman YAR, Bao J, Huang F, et al. Ginkgo biloba extract EGb761 attenuates hyperhomocysteinemia-induced AD like tau hyperphosphorylation and cognitive impairment in rats. Current Alzheimer Research 2018;15(1):89-99. [PMID: 28847282]
58. Zhao Y, Yu J, Liu J, An X. The role of Liuwei Dihuang pills and Ginkgo leaf tablets in treating diabetic complications. Evidence-based Complementary and Alternative Medicine: ECAM 2016;2016:7931314. [PMID: 28077949]
59. Zuo Wei, Yan Feng, Zhang Bo, Li Jiantao, Mei Dan. Advances in the studies of Ginkgo biloba leaves extract on aging-related diseases. Aging and Disease 2017;8(6):812-26.
60. Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD003120.pub2] [PMID: 17443523]
61. Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD003120.pub3] [PMID: 19160216]